MediXall Group, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.003773 million. Net loss was USD 1.39 million compared to USD 0.966631 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the nine months, sales was USD 0.173686 million. Net loss was USD 4.38 million compared to USD 3.96 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.04 a year ago.